-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
Standard Biotools Inc. annual Deferred Income Tax Expense (Benefit) history and growth rate from 2012 to 2023.
- Standard Biotools Inc. annual Deferred Income Tax Expense (Benefit) for 2023 was -$118 K, a 96.4% increase from 2022.
- Standard Biotools Inc. annual Deferred Income Tax Expense (Benefit) for 2022 was -$3.32 M, a 23.1% increase from 2021.
- Standard Biotools Inc. annual Deferred Income Tax Expense (Benefit) for 2021 was -$4.32 M, a 26.1% decline from 2020.
Deferred Income Tax Expense (Benefit), Annual (USD)
Deferred Income Tax Expense (Benefit), YoY Annual Growth (%)